Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

NCT02480114 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

79

Enrollment

OTHER

Sponsor class

Conditions

Malignant Head and Neck Neoplasm
Mucositis
Radiation-Induced Disorder

Interventions

OTHER: Educational Intervention
DRUG: Gabapentin
OTHER: Pain Therapy
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: Oxycodone/Acetaminophen
DRUG: Hydrocodone/Acetaminophen
DRUG: Fentanyl
DRUG: Ibuprofen
DRUG: Magic Mouthwash

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]